3-chloro-4'-cyano-diphenyl ether

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-chloro-4'-cyano-diphenyl ether
• 英文别名: 4-(3-Chlorophenoxy)benzonitrile
• 化学式: C₁₃H₈ClNO
• mdl: MFCD11135599
• 分子量: 229.666
• InChiKey: LLODVKYPISQHCC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  33
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-chloro-4'-cyano-diphenyl ether 在 potassium hydroxide 作用下， 以 水 为溶剂， 反应 12.0h， 以766 mg的产率得到4-(3-chlorophenoxy)benzoic acid
  参考文献：
  名称：

  Discovery of N-{4-[(3-Hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide Analogues as Selective Kappa Opioid Receptor Antagonists

  摘要：

  There is continuing interest in the discovery and development of new kappa opioid receptor antagonists. We recently reported that N-substituted 3-methyl-4-(3-hydroxyphenyl)piperazines were a new class of opioid receptor antagonists. In this study, we report the syntheses of two piperazine JDTic-like analogues. Evaluation of the two compounds in an in vitro [S-35]GTP gamma S binding assay showed that neither compound showed the high potency and kappa opioid receptor selectivity of JDTic. A library of compounds using the core scaffold 21 was synthesized and tested for their ability to inhibit [S-35]GTP gamma S binding stimulated by the selective kappa opioid agonist U69,593. These studies led to N-[(1S)-1-{[(3S)-4-(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyll-2-methylpropyl]-4-phenoxybenzamide (11a), a compound that showed good kappa opioid receptor antagonist properties. An SAR study based on 11a provided 28 novel analogues. Evaluation of these 28 compounds in the [S-35]GTP gamma S binding assay showed that several of the analogues were potent and selective kappa opioid receptor antagonists.

  DOI：

  10.1021/jm400275h
• 作为产物：
  描述：

  对甲氧基苯基TBDMS醚 、 对氟苯腈 在 P(i-BuNCH₂CH₂)3N 作用下， 以 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 4.0h， 以95%的产率得到3-chloro-4'-cyano-diphenyl ether
  参考文献：
  名称：

  P（i-BuNCH2CH2）3N：芳基氟化物与芳基TBDMS（或TMS）醚的亲核芳族取代反应的有效促进剂。

  摘要：

  [反应：请参见文字]。缺电子的芳基氟化物和芳基TBDMS（或TMS）醚之间的亲核芳族取代反应已显示出可以通过原七磷烷（例如P（i-BuNCH（2）CH（2））（3）N（3）有效地促进。在异常温和的条件下，可获得优异的二芳基醚产品收率。

  DOI：

  10.1021/ol051108s

文献信息

• (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL)
  作者：Angela Holtfrerich、Walburga Hanekamp、Matthias Lehr

  DOI：10.1016/j.ejmech.2013.01.050

  日期：2013.5

  Inhibitors of the enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), the principle enzymes involved in the degradation of endogenous cannabinoids like anandamide and 2-arachidonoylglycerol, have potential utility in the treatment of several disorders including pain, inflammation and anxiety. In the present study, the effectivity and selectivity of eight known FAAH and MAGL

  脂肪酸酰胺水解酶（FAAH）和单酰基甘油脂酶（MAGL）的抑制剂是参与降解内源性大麻素（如anandamide和2-arachidonoylglycerol）的主要酶，在治疗包括疼痛，炎症和焦虑症在内的多种疾病中具有潜在的用途。 。在本研究中，通过体外测定了八种已知的FAAH和MAGL抑制剂对适当酶的抑制作用的选择性和有效性。在可比较的条件下工作的分析方法。由于许多已知的FAAH和MAGL抑制剂仅由结合了杂环系统的亲脂性支架组成，因此，通过将不同的杂环结构连接到相同的亲脂性骨架（即4-苯氧基苯）上，评估了它们对酶抑制的作用。在此研究中合成的最具活性的化合物之一是N，N-二甲基-5-（4-苯氧基苯基）-2 H-四唑-2-羧酰胺（16）（IC 50 FAAH：0.012μM; IC 50MAGL：0.028μM）。该抑制剂在亲脂性4-苯氧基苯基区域被系统修饰。结构-活性关系研究表明，通过用3-
• P(i-BuNCH2CH2)3N: an efficient promoter for the microwave synthesis of diaryl ethers
  作者：Steven M. Raders、John G. Verkade

  DOI：10.1016/j.tetlet.2008.03.089

  日期：2008.5

  of aryl fluorides with aryl TBDMS ethers under microwave conditions gave moderate to high yields of the desired products at low catalyst loadings and in short times. In this methodology, electron deficient aryl fluorides possessing substituents, such as nitro, cyano, and ester, were coupled with sterically demanding aryl TBDMS ethers as well as with aryl TBDMS ethers bearing a variety of functionalities

  用标题的原氮杂磷杂环戊烷作为促进剂，在微波条件下芳基氟化物与芳基TBDMS醚的偶联在低催化剂负载量和短时间内得到中等至高产率的所需产物。在这种方法中，将具有取代基（例如硝基，氰基和酯）的缺电子的芳基氟化物与空间需求的芳基TBDMS醚以及带有各种官能团（例如甲氧基，卤素和氰基）的芳基TBDMS醚偶联。
• Discovery of Novel Isoxazoline Derivatives Containing Diaryl Ether against Fall Armyworms
  作者：Di Feng、Shang Wu、Biaobiao Jiang、Siqi He、Yuqin Luo、Fangyi Li、Baoan Song、Runjiang Song

  DOI：10.1021/acs.jafc.3c00824

  日期：2023.5.10

  frugiperda) with traditional insecticides. To solve this pending issue, a series of novel isoxazoline derivatives containing diaryl ether structures were designed and synthesized, and most of the target compounds exhibited excellent insecticidal activity. Based on the three-dimensional quantitative structure–activity relationship (3D-QSAR) model analysis, we further optimized the molecular structure with compound

  随着害虫抗药性的不断进化，传统杀虫剂防治秋粘虫（Spodoptera frugiperda ）是一个巨大的挑战。为了解决这一悬而未决的问题，设计合成了一系列含有二芳基醚结构的新型异恶唑啉衍生物，大多数目标化合物表现出优异的杀虫活性。基于三维定量构效关系（3D-QSAR）模型分析，我们进一步优化了分子结构，得到了化合物L35并测试了其活性。化合物L35 (LC 50 = 1.69 mg/L) 对草地夜蛾表现出优异的杀虫活性, 优于市售氟虫腈 (LC 50 = 70.78 mg/L) 和茚虫威 (LC 50 = 5.37 mg/L)。酶联免疫吸附试验表明，L35可以上调昆虫体内 GABA 的水平。此外，分子对接和转录组学结果也表明，化合物L35可能通过作用于GABA受体影响草地螽斯的神经系统。值得注意的是，通过高效液相色谱法（HPLC），我们能够得到化合物L35的两种对映体，杀虫活性测试表明S
• Chimeric derivatives of functionalized amino acids and α-aminoamides: Compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels
  作者：Robert Torregrosa、Xiao-Fang Yang、Erik T. Dustrude、Theodore R. Cummins、Rajesh Khanna、Harold Kohn

  DOI：10.1016/j.bmc.2015.04.014

  日期：2015.7

  Six novel 3 ''-substituted (R)-N-(phenoxybenzyl) 2-N-acetamido-3-methoxypropionamides were prepared and then assessed using whole-cell, patch-clamp electrophysiology for their anticonvulsant activities in animal seizure models and for their sodium channel activities. We found compounds with various substituents at the terminal aromatic ring that had excellent anticonvulsant activity. Of these compounds, (R)-N-4'-((3 ''-chloro) phenoxy) benzyl 2-N-acetamido-3-methoxypropionamide ((R)-5) and (R)-N-4'-((3 ''-trifluoromethoxy) phenoxy) benzyl 2-N-acetamido-3-methoxypropionamide ((R)-9) exhibited high protective indices (PI = TD50/ED50) comparable with many antiseizure drugs when tested in the maximal electroshock seizure test to mice (intraperitoneally) and rats (intraperitoneally, orally). Most compounds potently transitioned sodium channels to the slow-inactivated state when evaluated in rat embryonic cortical neurons. Treating HEK293 recombinant cells that expressed hNaV1.1, rNa(V)1.3, hNa(V)1.5, or hNa(V)1.7 with (R)-9 recapitulated the high levels of sodium channel slow inactivation. (C) 2015 Elsevier Ltd. All rights reserved.
• Discovery of <i>N</i>-{4-[(3-Hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide Analogues as Selective Kappa Opioid Receptor Antagonists
  作者：Chad M. Kormos、Chunyang Jin、Juan Pablo Cueva、Scott P. Runyon、James B. Thomas、Lawrence E. Brieaddy、S. Wayne Mascarella、Hernán A. Navarro、Brian P. Gilmour、F. Ivy Carroll

  DOI：10.1021/jm400275h

  日期：2013.6.13

  There is continuing interest in the discovery and development of new kappa opioid receptor antagonists. We recently reported that N-substituted 3-methyl-4-(3-hydroxyphenyl)piperazines were a new class of opioid receptor antagonists. In this study, we report the syntheses of two piperazine JDTic-like analogues. Evaluation of the two compounds in an in vitro [S-35]GTP gamma S binding assay showed that neither compound showed the high potency and kappa opioid receptor selectivity of JDTic. A library of compounds using the core scaffold 21 was synthesized and tested for their ability to inhibit [S-35]GTP gamma S binding stimulated by the selective kappa opioid agonist U69,593. These studies led to N-[(1S)-1-[(3S)-4-(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyll-2-methylpropyl]-4-phenoxybenzamide (11a), a compound that showed good kappa opioid receptor antagonist properties. An SAR study based on 11a provided 28 novel analogues. Evaluation of these 28 compounds in the [S-35]GTP gamma S binding assay showed that several of the analogues were potent and selective kappa opioid receptor antagonists.